Breast Neoplasms: all 12,820 studies
Page 7 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer PatientsNot yet recruitingNCT07370506Phase 1/2
- To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast CancerRecruitingNCT07368998Phase 2
- Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast CancerNot yet recruitingNCT07368543Phase 2
- The Influence of Chemotherapy on Position SenseNot yet recruitingNCT07367711
- Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer SurgeryNot yet recruitingNCT07367542Not applicable
- Effect of Mandala Coloring on Anxiety, Distress, and Comfort in Breast Cancer Patients Receiving Outpatient ChemotherapyRecruitingNCT07367269Not applicable
- Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast CancerNot yet recruitingNCT07367178Phase 2
- RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC FailureNot yet recruitingNCT07366840Phase 2/3
- CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant TreatmentRecruitingNCT07366112Phase 2
- Combined Exercise Effects in Breast Cancer-related LymphedemaNot yet recruitingNCT07365618Not applicable
- Study on the Cosmetic Outcome and Safety Evaluation of 3D Printed Biodegradable Biological Mesh for One-Stage Breast Reconstruction After Radical MastectomyRecruitingNCT07365267Not applicable
- The Effect of Group and Mobile Wellness Coaching Given to Women With Breast Cancer on the DiseaseNot yet recruitingNCT07364760Not applicable
- Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin ReactionsRecruitingNCT07362914Phase 3
- Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study)RecruitingNCT07362485Not applicable
- Anti-Ly6E Exatecan ADC M7437 in Advanced Solid TumorsRecruitingNCT07360314Phase 1
- Study to Assess the Effect of OCT-598 in Patients With Advanced Solid TumorsRecruitingNCT07358806Phase 1
- A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative CancerRecruitingNCT07358377Phase 1
- Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut CurieRecruitingNCT07357311
- Phase III Trial of Brain MRI Surveillance in Stage IV Breast CancerRecruitingNCT07357298Phase 3
- Self-Affirmation Intervention After MastectomyNot yet recruitingNCT07355244Not applicable
- Axelopran for Advanced Cancer in Patients Receiving OpioidsRecruitingNCT07354919Phase 2
- Accuracy of Sono-mammographic Features in Molecular Classification of Breast CancerNot yet recruitingNCT07354490
- Financial Toxicity in Patients With Early-stage Breast CancerRecruitingNCT07354165
- A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.RecruitingNCT07354022Phase 3
- Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination Repair (HRR) Mutated Primary Breast Cancer (Flamenco)Not yet recruitingNCT07353437Phase 2
- Endoscopic Nipple-Sparing Mastectomy (E-NSM) With Immediate Multistage Autologous Fat Grafting(IMAFG) for Total Breast Reconstruction Via the Axillary IncisionEnrolling by invitationNCT07352137Not applicable
- Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake StatusRecruitingNCT07350928Phase 3
- A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast CancerRecruitingNCT07349069Phase 3
- The Effect of a Health Belief Model-Based Education Program on Breast Self-Examination Practice Behavior, Breast Cancer Fear, and Awareness Levels in Women: A Randomized Controlled TrialNot yet recruitingNCT07348744Not applicable
- A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast CancerRecruitingNCT07347600
- Acellular Dermal Matrix(SureDerm BCS) in Breast-Conserving Surgery for Breast Cancer PatientsNot yet recruitingNCT07345026Not applicable
- Hand and Foot Bath for Taxane-Induced Peripheral NeurotoxicityNot yet recruitingNCT07344974Phase 4
- Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast CancerNot yet recruitingNCT07344597
- SL-28 for Advanced Solid TumoursRecruitingNCT07341737Phase 1/2
- A Prospective Clinical Study Investigating the Use of the Histolog Scanner for Intraoperative Assessment of Surgical Margins in Patients Undergoing Breast-conserving Surgery for Histologically Confirmed Breast Cancer. The Histolog Scanner Operates on the Principle of Confocal MicroscopNot yet recruitingNCT07341542
- The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer PatientsRecruitingNCT07341503
- A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast CancerNot yet recruitingNCT07340658Phase 3
- Evolutionary Clinical Trial for Novel Biomarker-Driven TherapiesRecruitingNCT07340541Phase 2
- JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast CancerNot yet recruitingNCT07336771Phase 1/2
- A Study of a Decision Tool for People Considering Breast Reconstruction SurgeryRecruitingNCT07335354Not applicable
- ctDNA in HER2+ EBC Neoadjuvant TreatmentRecruitingNCT07335081Phase 2
- Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsRecruitingNCT07334119Phase 1
- The Outcomes of Fat Grafting Combined With Latissimus Dorsi Muscle Flap for Delayed Breast Reconstruction After MastectomyRecruitingNCT07331753Not applicable
- Development and Application of a Parenting Anxiety Intervention Program for Young and Middle-Aged Female Breast Cancer PatientsNot yet recruitingNCT07331740Not applicable
- Validation of the Oncoliq Test for the Early Detection of Breast Cancer.RecruitingNCT07331506
- Evaluation of the Effect of Using Ultrasound Robots for Breast Cancer Screening: A Multicenter, Parallel-group, Cluster Randomized Controlled TrialRecruitingNCT07331363Not applicable
- A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine TherapyRecruitingNCT07330544Phase 2
- Natural History Study of Early Life Exposures in Agriculture (ELEA)Enrolling by invitationNCT07328516
- Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast CancerRecruitingNCT07327970
- MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBCRecruitingNCT07327021Phase 2
- A Retrospective Analysis of Robot-Assisted Versus Endoscopic Breast-Conserving Surgery for Breast CancerRecruitingNCT07321145Not applicable
- Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)RecruitingNCT07319195Early Phase 1
- A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid TumorsRecruitingNCT07318805Phase 1
- Sample Collection for Ongoing Research and Product Evaluation StudyRecruitingNCT07318051
- Incidence of Dysgeusia in Breast Cancer Patients Undergoing ChemotherapyNot yet recruitingNCT07317752
- [18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast CancerRecruitingNCT07314073Phase 2
- Self-management Interventions to Reduce Cardiovascular Risks in Breast Cancer SurvivorsNot yet recruitingNCT07313397Not applicable
- Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase ExerciseRecruitingNCT07313306Not applicable
- [68]GA-FAPI-46 PET/CT for the Diagnosis of Metastatic Lesions in Patients With Lobular Breast Cancer (ICL).Not yet recruitingNCT07313033Not applicable
- Phase 1 Study of CLR 125 in Triple Negative Breast CancerRecruitingNCT07311993Phase 1
- Cellular-Level Fluorescence Imaging for Intraoperative Margin Assessment in Breast CancerNot yet recruitingNCT07311317
- Endocrine Therapy Base on 21-gene RSNot yet recruitingNCT07311122
- Contrast-enhanced Ultrasound for Sentinel Node DetectionRecruitingNCT07310758Phase 2/3
- A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast CancerRecruitingNCT07310420Phase 1
- This Clinical Trial is a Retrospective, Multicenter Cohort Study Evaluating the Real-world Characteristics and Risk of Disease Recurrence in Hormone Receptor-positive, HER2-negative Early Breast Cancer.Not yet recruitingNCT07309887
- Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) ProtocolRecruitingNCT07308717Phase 4
- SHR-A1811 Plus Pertuzumab as Neoadjuvant Therapy for Early or Locally Advanced HR-Positive HER2-Positive Breast Cancer: A Prospective, Open-Label, Phase II StudyNot yet recruitingNCT07307287Phase 2
- Consensus on Skin Care in Breast Cancer PatientsEnrolling by invitationNCT07306130
- Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast CancerNot yet recruitingNCT07305246Phase 2
- A Prospective Multicenter Study of the TuFEst-LN Model for Axillary Lymph Node Status Assessment in Breast CancerRecruitingNCT07304934
- Behavioral Pain Intervention for Older Cancer PatientsRecruitingNCT07300995Not applicable
- An Exploratory Study on Individualized Neoadjuvant Treatment Regimens for Early HR+/HER2+ Breast CancerNot yet recruitingNCT07300215Phase 2
- An Exploratory Study of Pertuzumab and Trastuzumab in Combination With Palbociclib and Exemestane as Neoadjuvant Therapy for Triple-Positive Breast CancerNot yet recruitingNCT07299890Phase 2
- BRAVE-HEART: Breast Cancer Radiotherapy Using Active Breathing Coordinator to aVoid Exposure of HEARTRecruitingNCT07299812
- First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients.RecruitingNCT07299409Phase 2
- ExBRAC- Expressive Writing in Breast CancerEnrolling by invitationNCT07298980Not applicable
- ICG Lymphography Changes Before and After Radiotherapy in Breast Cancer PatientsRecruitingNCT07297927
- PTEN and Organ-Specific microRNAs in Metastatic Breast CancerRecruitingNCT07297134
- Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)RecruitingNCT07295457Not applicable
- Factors Associated With Breast Cancer Risks and OutcomesRecruitingNCT07294703
- A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat CancerNot yet recruitingNCT07294534Phase 2/3
- A Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast CancerRecruitingNCT07294508Phase 2/3
- Antibody-based PET Imaging and Treatment Response in Breast Cancer Treated With an Antibody-drug Conjugate.Not yet recruitingNCT07294430Phase 2
- Effect of Virtual Reality on Pain and Anxiety During Chemotherapy Session in Breast Cancer PatientsNot yet recruitingNCT07292727Not applicable
- Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107Enrolling by invitationNCT07292571Phase 2
- A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)RecruitingNCT07292246Not applicable
- Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast CancerNot yet recruitingNCT07292207Phase 2
- A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1RecruitingNCT07292168Phase 1/2
- FMT in Triple Negative Breast Cancer Guided by ctDNANot yet recruitingNCT07292142Phase 1/2
- A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer PatientsRecruitingNCT07291414Not applicable
- Survivors Uniting for Remote Guided ExerciseRecruitingNCT07290309Not applicable
- A Phase II Study to Evaluate the Efficacy and Safety of Anti-HER2 Triple-targeted Drugs Combined With CDK4/6 Inhibitors in Neoadjuvant Therapy for ER-positive HER2-positive Breast Cancer Patients.Not yet recruitingNCT07290166Phase 2
- Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBCRecruitingNCT07290153
- Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast CancerRecruitingNCT07289282
- Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid TumorsRecruitingNCT07288359Phase 1/2
- A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsRecruitingNCT07287995Phase 1/2
- Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid TumorsRecruitingNCT07287917Phase 1/2
- A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast CancerRecruitingNCT07287098Phase 2
- Precision Physical Exercise for Personalized Onco-Hematology.Not yet recruitingNCT07286539Not applicable
- Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PETNot yet recruitingNCT07285993Phase 2